Item request has been placed!
×
Item request cannot be made.
×
Processing Request
New contender in diabetes and obesity.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Mirasol, Feliza
- Source:
Chemical Market Reporter. 7/3/2006, Vol. 270 Issue 1, p23-23. 1/2p.
- Subject Terms:
- Additional Information
- Subject Terms:
- Abstract:
The article reports on the announcement of Pfizer in its intention of development of a potential new treatment for obesity, Type 2 diabetes and related disorders. Obesity and diabetes are fast becoming a near-epidemic levels and the need for new treatment options is in demand. The drug is undergoing a Phase I clinical development in Europe known as DGAT - 1 or diacylglycerol acyltransferase 1.
No Comments.